Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 14-Feb-24 4:01 PM View:  | Gordon Carl L Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 14-Feb-24 | Disposition (change in control) | 17,713,600 | -- | -- | (100%) 17.71M to 0 | |
| 14-Feb-24 4:01 PM View: | Hayden Donald J Jr Director | Theseus Pharmaceuticals, Inc. (THRX) | 14-Feb-24 | Disposition (change in control) | 10,000 | -- | -- | (100%) 10.0K to 0 | |
| 14-Feb-24 4:00 PM View: | Dukes Iain D. Director | Theseus Pharmaceuticals, Inc. (THRX) | 14-Feb-24 | Disposition (change in control) | 388,324 | -- | -- | (100%) 388.32K to 0 | |
| 14-Feb-24 4:02 PM View: | Orbimed Advisors LLC Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 14-Feb-24 | Disposition (change in control) Duplicate | 17,713,600 | -- | -- | (100%) 17.71M to 0 | |
| 14-Feb-24 4:00 PM View: | Dahms Bradford D. President and CFO | Theseus Pharmaceuticals, Inc. (THRX) | 14-Feb-24 | Disposition (change in control) | 8,150 | -- | -- | (100%) 8.15K to 0 | |
| 07-Nov-23 4:03 PM View: | Shakespeare William See Remarks | Theseus Pharmaceuticals, Inc. (THRX) | 06-Nov-23 | Option Exercise | 251,084 | $0.32 | $80,346.90 | 65% 388.32K to 639.41K | |
| 19-Jul-23 2:54 PM View: | Foresite Capital Management... 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 17-Jul-23 | Private Purchase | 700,000 | $2.97 | $2,079,000.00 | 15% 4.79M to 5.49M | |
| 19-Jul-23 4:15 PM View: | Orbimed Advisors LLC Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 17-Jul-23 | Private Purchase | 479,932 | $3.05 | $1,463,790.00 | 3% 17.23M to 17.71M | |
| 19-Jul-23 4:17 PM View: | Gordon Carl L Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 17-Jul-23 | Private Purchase Duplicate | 479,932 | $3.05 | $1,463,790.00 | 3% 17.23M to 17.71M | |
| 03-Jan-23 7:05 AM View: | Hayden Donald J Jr Director | Theseus Pharmaceuticals, Inc. (THRX) | 30-Dec-22 | Purchase | 9,900 | $5.00 | $49,489.10 | 9900% 100 to 10.0K | |
| 03-Jan-23 7:05 AM View: | Hayden Donald J Jr Director | Theseus Pharmaceuticals, Inc. (THRX) | 29-Dec-22 | Private Purchase | 100 | $5.00 | $500.00 | 100% 0 to 100 | |
| 03-Jan-23 4:24 PM View: | Foresite Capital Management... 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 29-Dec-22 | Private Purchase | 500,000 | $5.00 | $2,500,000.00 | 12% 4.29M to 4.79M | |
| 01-Dec-22 4:35 PM View: | Dahms Bradford D. Chief Financial Officer | Theseus Pharmaceuticals, Inc. (THRX) | 30-Nov-22 | Private Purchase | 1,502 | $6.66 | $10,000.10 | 32% 4.64K to 6.14K | |
| 14-Nov-22 4:12 PM View: | Clackson Timothy P President and CEO Director | Theseus Pharmaceuticals, Inc. (THRX) | 11-Nov-22 | Private Purchase | 2,500 | $6.80 | $16,995.00 | < 1% 348.53K to 351.03K | |
| 09-Nov-22 4:29 PM View: | Gordon Carl L Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 07-Nov-22 | Private Purchase Duplicate | 192,000 | $5.21 | $1,000,320.00 | 1% 17.04M to 17.23M | |
| 09-Nov-22 4:25 PM View: | Orbimed Advisors LLC Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 07-Nov-22 | Private Purchase | 192,000 | $5.21 | $1,000,320.00 | 1% 17.04M to 17.23M | |
| 21-Jan-22 7:22 PM View: | Gordon Carl L Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 21-Jan-22 | Market Purchase Duplicate | 111,896 | $9.97 | $1,115,600.00 | < 1% 16.93M to 17.04M | (1%) |
| 21-Jan-22 7:18 PM View: | Orbimed Advisors LLC Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 21-Jan-22 | Market Purchase | 111,896 | $9.97 | $1,115,600.00 | < 1% 16.93M to 17.04M | (1%) |
| 21-Jan-22 7:18 PM View: | Orbimed Advisors LLC Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 20-Jan-22 | Market Purchase | 35,000 | $9.95 | $348,250.00 | < 1% 16.89M to 16.93M | (1%) |
| 21-Jan-22 7:22 PM View: | Gordon Carl L Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 20-Jan-22 | Market Purchase Duplicate | 35,000 | $9.95 | $348,250.00 | < 1% 16.89M to 16.93M | (1%) |
| 21-Jan-22 7:22 PM View: | Gordon Carl L Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 19-Jan-22 | Market Purchase Duplicate | 11,521 | $9.97 | $114,864.00 | < 1% 16.88M to 16.89M | (1%) |
| 21-Jan-22 7:18 PM View: | Orbimed Advisors LLC Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 19-Jan-22 | Market Purchase | 11,521 | $9.97 | $114,864.00 | < 1% 16.88M to 16.89M | (1%) |
| 13-Jan-22 7:27 PM View: | Gordon Carl L Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 13-Jan-22 | Market Purchase Duplicate | 17,320 | $9.43 | $163,328.00 | < 1% 16.87M to 16.88M | 4% |
| 13-Jan-22 7:18 PM View: | Orbimed Advisors LLC Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 13-Jan-22 | Market Purchase | 17,320 | $9.43 | $163,328.00 | < 1% 16.87M to 16.88M | 4% |
| 13-Jan-22 7:18 PM View: | Orbimed Advisors LLC Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 12-Jan-22 | Market Purchase | 18,897 | $10.06 | $190,104.00 | < 1% 16.85M to 16.87M | (2%) |
| 13-Jan-22 7:27 PM View: | Gordon Carl L Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 12-Jan-22 | Market Purchase Duplicate | 18,897 | $10.06 | $190,104.00 | < 1% 16.85M to 16.87M | (2%) |
| 13-Jan-22 7:27 PM View: | Gordon Carl L Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 11-Jan-22 | Market Purchase Duplicate | 8,500 | $10.51 | $89,319.00 | < 1% 16.84M to 16.85M | (6%) |
| 13-Jan-22 7:18 PM View: | Orbimed Advisors LLC Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 11-Jan-22 | Market Purchase | 8,500 | $10.51 | $89,319.00 | < 1% 16.84M to 16.85M | (6%) |
| 22-Dec-21 6:26 PM View: | Clackson Timothy P President and CEO Director | Theseus Pharmaceuticals, Inc. (THRX) | 21-Dec-21 | Market Purchase | 2,600 | $9.76 | $25,381.50 | < 1% 345.93K to 348.53K | (3%) |
| 14-Oct-21 5:00 PM View: | Orbimed Advisors LLC Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 12-Oct-21 | Conversion | 16,213,700 | -- | -- | 100% 0 to 16.21M | |
| 14-Oct-21 5:00 PM View: | Rock Springs Capital Manage... 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 12-Oct-21 | Market Purchase | 250,000 | $16.00 | $4,000,000.00 | 57% 436.65K to 686.65K | |
| 15-Oct-21 6:40 PM View: | Takeda Pharmaceutical Co Ltd 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 12-Oct-21 | Conversion | 1,615,430 | -- | -- | 100% 0 to 1.62M | |
| 14-Oct-21 4:40 PM View: | Omega Fund Vi, L.P. | Theseus Pharmaceuticals, Inc. (THRX) | 12-Oct-21 | Conversion | 523,979 | -- | -- | 100% 0 to 523.98K | |
| 14-Oct-21 5:00 PM View: | Orbimed Advisors LLC Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 12-Oct-21 | Market Purchase | 625,000 | $16.00 | $10,000,000.00 | 4% 16.21M to 16.84M | |
| 14-Oct-21 5:00 PM View: | Shakespeare William See Remarks | Theseus Pharmaceuticals, Inc. (THRX) | 12-Oct-21 | Market Purchase | 625 | $16.00 | $10,000.00 | < 1% 388.32K to 388.95K | (3%) |
| 14-Oct-21 5:00 PM View: | Gordon Carl L Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 12-Oct-21 | Conversion Duplicate | 16,213,700 | -- | -- | 100% 16.21M to 32.43M | |
| 14-Oct-21 4:40 PM View: | Omega Fund Vi, L.P. | Theseus Pharmaceuticals, Inc. (THRX) | 12-Oct-21 | Market Purchase | 187,500 | $16.00 | $3,000,000.00 | 36% 523.98K to 711.48K | |
| 14-Oct-21 5:00 PM View: | Rock Springs Capital Manage... 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 12-Oct-21 | Conversion | 436,649 | -- | -- | 100% 0 to 436.65K | |
| 14-Oct-21 5:00 PM View: | Gordon Carl L Director 10% Owner | Theseus Pharmaceuticals, Inc. (THRX) | 12-Oct-21 | Market Purchase Duplicate | 625,000 | $16.00 | $10,000,000.00 | 2% 32.43M to 33.05M |
